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Abstract
The cross-talk at the prefronto-striatal interface involves excitatory amino acids, different receptors, transducers and
modulators. We investigated long-term effects of a prepuberal, subchronic 5-HT7-R agonist (LP-211) on adult behaviour,
amino acids and synaptic markers in a model for Attention-Deficit/Hyperactivity Disorder (ADHD). Naples High Excitability
rats (NHE) and their Random Bred controls (NRB) were daily treated with LP-211 in the 5th and 6th postnatal week. One
month after treatment, these rats were tested for indices of activity, non selective (NSA), selective spatial attention (SSA) and
emotionality. The quantity of L-Glutamate (L-Glu), L-Aspartate (L-Asp) and L-Leucine (L-Leu), dopamine transporter (DAT),
NMDAR1 subunit and CAMKIIa, were assessed in prefrontal cortex (PFC), dorsal (DS) and ventral striatum (VS), for their role
in synaptic transmission, neural plasticity and information processing. Prepuberal LP-211 (at lower dose) reduced horizontal
activity and (at higher dose) increased SSA, only for NHE but not in NRB rats. Prepuberal LP-211 increased, in NHE rats, L-Glu
in the PFC and L-Asp in the VS (at 0.250 mg/kg dose), whereas (at 0.125 mg/kg dose) it decreased L-Glu and L-Asp in the DS.
The L-Glu was decreased, at 0.125 mg/kg, only in the VS of NRB rats. The DAT levels were decreased with the 0.125 mg/kg
dose (in the PFC), and increased with the 0.250 mg/kg dose (in the VS), significantly for NHE rats. The basal NMDAR1 level
was higher in the PFC of NHE than NRB rats; LP-211 treatment (at 0.125 mg/kg dose) decreased NMDAR1 in the VS of NRB
rats. This study represents a starting point about the impact of developmental 5-HT7-R activation on neuro-physiology of
attentive processes, executive functions and their neural substrates.
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Introduction
The interface between the prefrontal cortex (PFC) and the
striata represents the neural substrate for the parallel processing of
cognitive and non-cognitive information [1,2]. Therefore, this
neural site has been the target of neurophysiological and imaging
studies in relation to neuropsychiatric problems [3,4]. The
neurogenetic approach in model systems has been used so far to
study complex behaviour [5,6] and its neural substrates. This
approach will likely lead to a better understanding of neuropsy-
chiatric problems such as Attention-Deficit Hyperactivity Disorder
(ADHD), Autism, Schizophrenia and Depression.
In the mammalian brain, the communication between the PFC
and the dorsal/ventral striatum involves the amino acid L-
Glutamate (L-Glu) acting through different ionotropic [7] and
metabotropic receptors, transduction mechanisms and various
modulators [8,9]. The latter include dopamine (DA), norepineph-
rine (NE), serotonin (5-HT), and histamine. A series of clinical,
pharmacological, biochemical and molecular biology studies have
supported the ‘‘dopamine hypothesis’’ in the last fifty years
[10,11], which has yielded a wealth of information giving rise to a
major knowledge in the field of neurosciences. For instance, in the
case of ADHD, DA-ergic psychostimulant drugs like methylphe-
nidate (MPH) and the amphetamines have been largely used.
Notwithstanding, the amino acid transmission between the PFC
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and the striata is modulated by 5-HT that is released by axon
terminals of raphe nuclei and may operate through seven receptor
families. Among these, the 5-HT7 receptor subtype is the target of
LP-211, a newly synthesised selective agonist [12,13]. It is likely to
hypothesise that this receptor could serve a new therapeutic target
for ADHD and other neuropsychiatric problems sharing attention
deficit.
Therefore, in this manuscript we attempt to investigate long-
term effects of a prepuberal, subchronic treatment, by LP-211, on
adult behaviour, amino acid transmitters and synaptic markers,
using a well documented rat model for ADHD [14]. Animal
models for studying ADHD can be of genetic and non-genetic type
[15]. The Naples High Excitability (NHE) rat is a classically
validated genetic model, which reproduces the mesocortical
variant of ADHD [6,14,16,17]. In particular, their profile is
characterised by a dysfunctioning mesocortical DA branch with an
attention deficit, hyperactivity and altered executive functions.
Therefore, adolescent male rats of the Sprague-Dawley-derived
NHE line, and their Naples Random-Bred (NRB) [6,16] controls,
received daily exposure to LP-211 (0.0, 0.125, 0.250 or 0.500 mg/
kg), from post-natal day 30–31 to 43–44.
By using a multidisciplinary approach, here we show that
prepuberal LP-211 yields long lasting changes on adult behaviour,
improving spatial attention in a dose dependent manner,
associated with modified expression of pre- and post-synaptic
markers.
The results of the present experiments may represent an
important starting point to explore how selective 5-HT7 receptor
stimulation can impact upon the neurophysiology of attentive
processes, executive functions and their neural substrates. This
may, in turn, lead to a better understanding of developmental




To evaluate possible LP-211 developmental-treatment influenc-
es on body growth, the body weight was measured in all groups
analyzed. There were no differences across groups in NHE and
NRB rats. In fact, separate two-way factorial ANOVAs on NHE
and NRB rats, with treatment x time (as covariate), showed no
main effect for treatment but only for age (time, F= 4111.3 and
832.94; df = 1/26 and 2/45; p,0.0001 for both) with no
interaction.
Long-term behavioural effects of adolescent LP-211 in
rats
Behavioural tests were carried out on young adult rats (pnd 70–
75 days) so that long-term effects of prepuberal subchronic LP-211
treatment could be determined. The behavioural tests consisted of
short exposure of the rats to spatial novelties paradigms, i.e. La`t
and Olton mazes. The main variables were total activity, non
selective and selective spatial attention (NSA, SSA), and emotion-
ality index in Broadhurst’s terms [18]. Exposure to spatial
novelties within a La`t maze (Figure 1A–C) yielded no significant
treatment effect for NHE and NRB rats, in separate univariate
ANOVAs for indices of activity, i.e. both horizontal activity (HA,
panel A) and vertical activity (VA, panel B) as well as rearing
duration (RD, panel C). Exposure to spatial novelties within a
Olton’s eight-arm radial maze shows that LP-211 treatment
reduced exploratory HA activity only in the NHE rats (Figure 2A)
(one-way ANOVA: effect for treatment (F= 3.56; df = 3/20; p,
0.033) and for time (F = 4.886; df = 5/110; p,0.000) with no
treatment per time interaction). The post-hoc LSD test confirmed
that the reduction of HA produced by LP-211 was due to the
0.125 mg/kg dose (p,0.0064). On the other hand, the vertical
activity in both NHE and NRB rats, VA and RD, were not
influenced by prepuberal LP-211 treatment (one-way ANOVAs:
no significant treatment effect on VA and RD) as was observed in
the La`t maze (Figure 2B–C).
For the selective spatial attention (SSA), the two markers of non-
reinforced SSA are depicted in Figure 3 panels A and B,
respectively. The position of the First repetitive arm Entry (FE)
significantly improved only in NHE rats, as demonstrated by one-
way ANOVA (F=3.908; df = 3/20; p,0.024). Post-hoc LSD test
showed that the higher score was due to the 0.250 mg/kg dose of
LP-211 (p,0.0087). In contrast, the other parameter, i.e. the total
Number of alley Visits needed To Criterion (NVTC), was not
different among groups, as demonstrated by one-way ANOVA.
The defecation score, used as an emotionality index in Broadhurst
terms, was not different across treatment groups and behavioural
tasks (La`t and Olton mazes), as demonstrated by separate
Kruskal–Wallis tests within the NHE and NRB rats.
Long-term effects of LP-211 on biochemical parameters
in adult rats
It is very well known the role of excitatory amino acids in the
synaptic dialogue between the pre-frontal cortex (PFC) and the
dorsal/ventral striatum (DS/VS) [19,20]. L-Glu and L-Asp can
play a role in synaptic transmission, neural plasticity and
information processing [21]. After the completion of behavioural
tests, the various groups of rats were analyzed for the ex-vivo levels
of the amino acids L-Glu, L-Asp and L-Leucine in the PFC, DS
and VS by LC/MS/MS. The choice of L-Asp was based on its
hypothesised role in neurotransmission as suggested by D’Aniello
et al. [22] and for its proposed involvement in the formation of N-
Methyl D-aspartate (NMDA). In fact, L-Asp can be converted into
the stereoisomer D-aspartate by the racemase enzyme, then be
inserted as such into NMDA by the N-Methyl transferase and act
as an agonist at NMDA receptors [22,23].
Excitatory amino acids L-Glu and L-Asp were expressed as a
ratio over L-Leu that does not participate into neurotransmission.
Moreover, they were measured in the soluble fraction that
corresponds to the one sampled by the microdyalisis method
[24]. Data pertaining to the forebrain sites are shown (Figure 4A:
NHE and Figure 4B: NRB).
Prefrontal Cortex. Separate one-way ANOVAs on NHE
and NRB rats showed an increased ratio of L-Glu/L-Leu
(F = 6.14; df = 2/15, p,0.011) for LP-211 at 0.250 mg/kg dose
in the NHE line (Figure 4A). Conversely, no significant changes
were observed for any of the doses in NRB rats (Figure 4B).
Furthermore, the level of L-Asp/L-Leu did not vary in the PFC of
NHE or NRB rats for any of the doses (Figure 4A–B).
Dorsal Striatum. In the DS, separate one-way ANOVAs on
NHE and NRB rats revealed a decreased L-Glu/L-Leu ratio only
for the 0.125 mg/kg dose (F= 7.23; df = 2/15, p,0006) in the
NHE line. In contrast, no significant difference was observed in
the levels of L-Glu/L-Leu in the NRB line. Furthermore, the L-
Asp/L-Leu ratio was also reduced at the 0.125 mg/kg dose
(F = 11.50; df = 2/15, p,0.001) in the NHE rats. No significant
changes were observed across amino acids and LP-211 doses in the
NRB rats (Figure 4B).
Ventral Striatum (or nucleus accumbens). Finally, the
levels of L-Glu/L-Leu in the VS of NHE rats showed no
significant differences. Separate one-way ANOVAs on NHE and
NRB rats demonstrated a reduced L-Glu/L-Leu ratio in the VS
for the 0.125 mg/kg dose (F = 6.43; df = 2/15; p,0.010), only in
LP-211 and Behavior in NHE and NRB Rats
PLOS ONE | www.plosone.org 2 April 2014 | Volume 9 | Issue 4 | e83003
Figure 1. Long term behavioural effects of prepuberal subchronic LP-211 treatment on activity and non selective attention in the
La`t maze for adult NHE and NRB rats. The frequency of corner crossings (A), the frequency of rearings (B), and their duration (C) after vehicle or
treatment with 0.125, 0.250 or 0.500 mg/kg LP-211 are reported as mean 6 SEM, (N = 6/group). For statistical analysis see the Results section.
doi:10.1371/journal.pone.0083003.g001
LP-211 and Behavior in NHE and NRB Rats
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NRB rats (Figure 4B). Moreover, there was an increased L-Asp/L-
Leu ratio (F= 7.887, df = 2/14, p,0.005) for the 0.250 mg/kg
dose in the NHE line (Figure 4A). The increased L-Glu in the PFC
and L-Asp in the VS, produced by the 0.250 mg/kg dose within
the NHE line, were the most relevant findings from the point of
view of fronto-striatal cross talk.
Long-term effects of LP-211 on neuronal substrate in
adult rats
Long term changes in neural substrates were detected using, as
molecular probes, the synaptic transmission markers dopamine
transporter (DAT), NMDAR1 subunit and calcium-calmodulin-
dependent kinase type II alfa (CaMKIIa). DAT has been chosen
as presynaptic marker [25,26], NMDAR1 as postsynaptic marker
[27], whereas CaMKIIa served as an intracellular coincidence
detector device [28]. Data pertaining to specific brain areas are
shown in Figures 5, 6, 7, 8, and 9.
Ex-vivo levels of DAT protein. In the PFC, the one-way
ANOVA on the DAT level of NHE rats, treated with vehicle,
0.125 mg/kg or 0.250 mg/kg LP-211, showed a significant
reduction at 0.125 mg/kg dose (F = 14.02; df = 1/9; p,0.006)
(Figure 5A). This reduction was about 20% of the vehicle control.
The dose of 0.250 mg/kg had no significant effect. Conversely, no
significant difference was found in the PFC of NRB rats
(Figure 5B). In the DS, separate one-way ANOVAs showed no
significant effects due to treatment on DAT level of NHE and
NRB rats (Figure 5A–B). In the VS, the one-way ANOVA on
DAT level of NHE rats, treated with vehicle or LP-211, showed a
significant treatment effect only at the 0.250 mg/kg dose
(Figure 5A). In fact, there was an increase in DAT protein level
(F = 14.39; df = 1/10; p,0.004) that accounted for 100%. In
contrast, no significant differences were observed again in NRB
rats (Figure 5B). Finally, within the Mesencephalon (ME), the
separate one-way ANOVAs, on DAT level for NHE and NRB
rats, showed no significant effect due to prepuberal treatment with
vehicle or LP-211 (Figure 5A–B).
Ex vivo levels NMDAR1 protein. The goal of these
experiments was to verify whether the higher density of the
NMDAR1 subunit, found in the PFC of NHE rats, could be
modified by stress-associated vehicle injections and/or LP-211
treatment at adolescence. NMDAR1 protein level in the PFC of
NHE and NRB rats, under basal conditions, are shown in
Figure 6A. Separate one-way ANOVAs showed a higher
NMDAR1 level in NHE rats (F = 10.10; df = 1/7; p,0.019). This
increase was about 75% compared to the NRB controls. A higher
level of NMDAR1 was also found within the VS (Figure 6B) of
NHE rats, but one-way ANOVA showed no significant difference
versus controls.
NMDAR1 protein levels in the brain areas (PFC; DS; VS) of
NHE rats, treated with vehicle, 0.125 mg/kg or 0.250 mg/kg LP-
211, are shown in Figure 7A. The separate one-way ANOVAs
revealed no significant differences for NMDAR1 levels in the PFC,
the DS and the VS of NHE rats, and this for all LP-211 treatment
dosages. No significant changes were identified from the analysis of
the PFC and DS data from NRB rats (Figure 7B). In the VS of
NRB rats, treated with LP-211 at 0.125 mg/kg dose, the protein
level was about 45% of that found in the vehicle-treated controls
(F = 18.65; df = 1/8; p,0.003). A very similar but not significant
reduction was observed for the 0.250 mg/kg dose.
Ex-vivo levels of CaMKIIa protein. The spatio-temporal
coincidence detector CaMKIIa [28] was chosen for its integrator
function in the intracellular traffic signalling, in relation to
complex behaviours. Therefore, LP-211 treatment could modify
this molecular device. CaMKIIa protein levels were analysed by
western blot in the forebrain of NHE and compared to NRB rats,
to determine the long-term effect of the adolescent treatment with
vehicle, 0.125 mg/kg or 0.250 mg/kg LP-211 (Figure 8). Separate
one-way ANOVAs on NHE and NRB rats showed, under basal
conditions, a lower level of CaMKIIa in the PFC (F= 6.19; df = 1/
7; p,0.042) of NHE compared to NRB rats (Figure 8A). This
reduction accounted for 29.6% of the NRB level assumed as
100%. By contrast, an increased protein level was observed in the
DS (F= 6.13; df = 1/11; p,0.033; Figure 8B). No significant
differences were observed in the VS (Figure 8C). Long lasting
effects of LP-211 prepuberal treatment were not observed in NHE
and NRB rats (Figure 9A and B, respectively).
Discussion
The rationale for these studies was to investigate whether and to
what extent a prepuberal subchronic stimulation of serotonin 7
subtype receptors (5-HT7-R), by the selective LP-211 agonist,
would produce long term effect on adult behaviour, amino acid
transmitters and synaptic markers. This was carried out using a
validated animal model of hyperactivity and attention deficit, the
NHE line, and compared to the NRB control rats.
A prepuberal subchronic design was chosen based on the
assumption that i) the prepuberal period is ‘‘critical’’ for the
organisation of neural networks in the developing forebrain, and
that these sites are sensitive to genotype x environment interac-
tions [29]; ii) that repeated administration of a 5-HT7-targeting
agonist would trigger a cascade of events leading eventually to
enhanced neural plasticity [30–32].
By using a multi-disciplinary approach, we show that adolescent
exposure to LP-211 yields long lasting changes on adult behaviour,
improving spatial attention in a dose dependent manner,
associated with modified pre/post synaptic markers.
Long term behavioural effects persisting into adulthood
Prepuberal subchronic treatment apparently modified neural
circuits underlying locomotor activity, NSA and SSA, as
monitored in adulthood by exposure to two spatial novelty
paradigms (i.e. La`t and Olton mazes). Under basal conditions, the
NHE rats showed a higher frequency of leanings than NRB rats
[14]. In NHE rats, 0.125 mg/kg LP-211 during adolescence
reduced adult horizontal activity. The sub-chronic prepuberal
treatment with the intermediate 0.250 mg/kg LP-211 dose
produced significantly improved SSA that persisted into adult-
hood, even though it had no long-term effect on the frequency of
rearings and leanings. The performance of these animals in the
Olton’s maze was almost perfect, indicating enhanced attention to
spatial information and suggesting improved hippocampal func-
tion. The LP-211 treatment of adolescent rats has been recently
demonstrated [33] to rearrange forebrain networks, with a central
role of hippocampal connections, a finding which in turn confirms
the emerging importance of 5-HT7 receptors for learning and
memory processes. Thus, results are consistent with previous
reports in rats [13,34].
In particular, the stimulation of 5-HT(7) receptors could
alternatively have been induced by a mixed 5-HT(1A/7) agonist
with the help of a 5-HT(1A) selective antagonist [35–37]. This
classic approach has been presently overcome by the availability of
a direct 5-HT(7) agonist. It has been suggested that 5-HT(7)
stimulation impairs short-term memory while improving long-
term memory, and that acquisition requires silencing of 5-HT(7)
while consolidation requires its activation [13,34,38]. For instance,
5-HT(7) antagonists are able to reverse a working memory deficit
[39]. No effect has been reported under our experimental
LP-211 and Behavior in NHE and NRB Rats
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Figure 2. Long term behavioural effects of prepuberal subchronic LP-211 treatment on activity and non selective attention in the
Olton maze for adult NHE and NRB rats. The horizontal activity (A), the frequency of rearings (B) and their duration (C) after vehicle or treatment
with 0.125, 0.250 or 0.500 mg/kg LP-211 are reported as mean 6 SEM, (N = 6/group). For statistical analysis see the Results section (* p,0.01).
doi:10.1371/journal.pone.0083003.g002
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conditions (of prepuberal subchronic LP-211 exposure) on anxiety
level, as monitored by elevated Zero-maze in the NHE rat line
[40]. Therefore, we hypothesize that the beneficial effect of LP-
211 on SSA might be due to enhanced attentive processes/
mechanisms rather than to reduced emotionality. The absence of
an effect by LP-211 on behavioural variables in the La`t maze, and
the reduced horizontal activity in the Olton’s maze, might be
tentatively explained by the differential effect of 5-HT(7)
stimulation on egocentric versus allocentric spatial mapping
[38]. Indeed, spatial mapping in these two paradigms reveals a
different neural mechanism: egocentric in the La`t maze and
allocentric in the Olton’s maze [41]. Thus, we have identified a
second significant effect on spatial orientation, in addition to that
induced previously by intranasal dopamine (INDA) treatment with
the 0.150 mg/kg dose [42].
Long term effects on amino acids and synaptic markers
into adulthood
Excitatory amino acids. The ratio of Glutamate and
Aspartate over Leucine, an amino acid not involved in neuro-
Figure 3. Long term behavioural effects of prepuberal subchronic LP-211 treatment in the Olton maze. Spatial selective attention: the
position of first repetitive arm visit (FE; panel A) and number of arm visits before all arms are visited (NVTC; panel B) are reported for the NRB and NHE
rats. An efficient rat will explore the eight arms only one time, thus the best score should be 9 for first error, and 8 for number of arm visits to
criterion. Data after vehicle or treatment with 0.125, 0.250 or 0.500 mg/kg LP-211 are presented as mean6 SEM, (N= 6/group). For statistical analysis
see the Results section (* p,0.01).
doi:10.1371/journal.pone.0083003.g003
LP-211 and Behavior in NHE and NRB Rats
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transmission, pertained only to the soluble forms and was
comparable to that measured in micro-dialysis [24]. This was
presently an attempt to study, within ex vivo tissues, the
compartmentalisation of excitatory amino acids in the mammalian
brain. The soluble form includes amino acids that can be washed
out with cold saline together with part of the neuro-glial
component. Amino acids are distributed in three main heteroge-
neous pools, for which a homeostasis has been proposed by
Kalivas [43]. These include a very large metabolic pool (10
milliMoles) of neuro-glial origin, a smaller vesicular pool and an
even smaller extra synaptic pool [44]. In addition, they are not
independent as L-Glu, first stored in the glial pool, is transferred to
the neuron as glutamine, then is deaminated back to L-Glu and
finally packed into vescicles to be secreted into the synaptic cleft.
Therefore, and even though the metabolic compartment over-
whelms the others by its size (10 mM), the higher level of L-Glu
should be proportionally distributed among the three pools. On
the other hand, L-Asp was measured, as mentioned in the
Introduction, because of its hypothesised role in the formation of
NMDA molecules, which are agonists at the NMDA receptor sites.
Therefore, L-Asp data should be considered in conjunction with
NMDAR1 binding sites (see below). We predict that the beneficial
effect of adolescent LP-211 is due to altered amino acid
transmission. This, in turn, may prevent glutamate neurotoxicity
Figure 4. Level of Glu/Leu (black) and Asp/Leu (white) expressed as ratio in PFC, DS and VS of NHE (panel A) and NRB (panel B) rats.
Data after vehicle or treatment with 0.125 or 0.250 mg/kg LP-211 are presented as mean 6 SEM, (N = 6/group). For statistical analysis see the Results
section (* p,0.02).
doi:10.1371/journal.pone.0083003.g004
LP-211 and Behavior in NHE and NRB Rats
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- that imaging studies have shown to be the basis for right fronto-
striatal atrophy in ADHD [45,46]. Adolescent exposure to LP-211
yielded indeed two major consequences: i) it decreased L-Glu and
L-Asp in the DS after treatment with the 0.125 mg/kg dose and ii)
it increased L-Glu in PFC and L-Asp in the VS after treatment
with the 0.250 mg/kg dose, both in the NHE rats. L-Glu also
decreased, after prepuberal subchronic treatment with 0.125 mg/
kg LP-211, only in the VS of control NRB rats. Thus, prepuberal
exposure to serotonergic stimulation permanently modifies neural
areas and forebrain circuits underlying activity, motivation and
attention, but not emotionality. By focussing on the prefronto-
striatal interface, the most relevant change was produced by
adolescent exposure to 0.250 mg/kg LP-211, with persistent
amino acid changes found in both PFC and VS of an animal
model for hyperactivity and attention deficit.
Synaptic markers. The presynaptic DAT, the post-synaptic
NMDAR1 and CaMKIIa markers, studied under basal condi-
tions, showed that NMDAR1 levels within the PFC of NHE rats
were higher, in comparison with NRB rats; by contrast, no
differences were found within the DS. Moreover, NHE rats
showed a significant reduction in the amount of CaMKIIa within
the PFC, while previous findings [47,14] have shown that DAT
level within the PFC is higher for NHE. Conversely, an increased
level of CaMKIIa was detected in the DS while the VS did not
show any difference between NHE and NRB rats. Finally, the
Figure 5. Level of DAT protein measured by western blot in the PFC, DS, VS and ME of NHE (panel A) and NRB (panel B) rats after
adolescent treatment with 0.125 or 0.250 mg/kg LP-211. Data are given as % of vehicle response 6 standard error. For statistical analysis see
the Results section (* p,0.05).
doi:10.1371/journal.pone.0083003.g005
Figure 6. Level of NMDAR1 protein measured in the PFC (panel A) and VS (panel B) of NHE and NRB rats under basal conditions.
Data are presented as mean 6 standard error. For statistical analysis see the Results section (* p,0.05).
doi:10.1371/journal.pone.0083003.g006
LP-211 and Behavior in NHE and NRB Rats
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level of CaMKIIa in the mesencephalon - though very low [48] -
was found to be higher in NHE rats.
Treatment with LP-211 during adolescence gave the following
findings that persisted into adulthood: 1) DAT level in the PFC
was decreased at the 0.125 mg/kg dose and conversely increased
in the VS at the 0.250 mg/kg, but only in NHE rats. The
adolescent prepuberal treatment produced no differences in all
areas of NRB control subjects; 2) NMDAR1 was decreased in the
VS of NRB rats when previously faced with the prepuberal
subchronic exposure to a 0.125 mg/kg dose; 3) prepuberal
subchronic LP-211 exposure exerted no long-term effect on
CaMKIIa levels in either line and in all areas. It is noteworthy that
CaMKIIa level has been reported to be lower in the forebrain of
animal models for ADHD, such as SHR and NHE rats [49–51].
Altogether, the most relevant change was produced by the
0.250 mg/kg dose of LP-211: adolescent exposure to this dose
generated, as a sequel into adulthood, an improved spatial
orientation as well as persistently elevated L-Asp and DAT levels
in the VS and L-Glu levels in the PFC. The simplest interpretation
of these results is that the cross-talk between the PFC and VS
might have been improved.
Prefronto-striatal interface in model systems
The ‘‘dialogue’’ between the PFC and both the DS and VS,
occurring through glutamate and aspartate, is modulated mainly
by DA, NA, 5-HT and histamine. Our experimental evidence
suggests that only two signaling modulators (DA and 5-HT) are
effective in inducing long-term changes within neural networks,
Figure 7. Level of NMDAR1 protein measured by western blot in the forebrain sites of NHE (panel A) and NRB (panel B) rats after
adolescent treatment with 0.125 or 0.250 mg/kg LP-211. Data are presented as % of vehicle response6 standard error. For statistical analysis
see the Results section (* p,0.05).
doi:10.1371/journal.pone.0083003.g007
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which are known to underlie attentive and motivational processes.
In fact, prepuberal subchronic treatments with MPH and ATX,
which block the reuptake of DA/NE and NE, respectively, did not
similarly alter the SSA in adult rats, in spite of significant effects on
DA, NA, 5-HT and metabolites at the prefronto-striatal interface
in NHE rats [52]. By contrast, we found previously that an INDA-
based prepuberal subchronic treatment is effective at a low dose
(0.075 mg/kg) [53].
This profile of effects is likely to be explained because DA has
the following functions: i) at mesencephalic level, DA can interact
with DA-D2 autoreceptors, associated with hyper-polarising
potassium conductances, thereby reducing the firing rate of DA
neurons [54] and ii) at 0.150 mg/kg dose, DA can induce the
synthesis of neurotrophic factors of the BDNF type [55]. On the
other hand, the MPH-induced DA increase, caused by MPH itself
and ATX, clearly suggests that the DA signal is much more
effective in the absence of other modulator signals.
The fact that the developmental stimulation of 5-HT7 receptors
(by the selective agonist LP-211) is just as effective as DA-related
drugs in modifying the long-term SSA in NHE rats requires
further experimental investigations. One clue is given by the fact
that 5-HT7 is found to be functionally linked to forebrain limbic
networks, which comprise the amygdala, VS, orbital PFC, and
thalami [33]. Moreover, a recent report [56] demonstrated that
serotonin acts on inhibitory interneurons in the PFC through Gs
proteins. The PFC-mediated inhibitory control over subcortical
structures might well be mediated by 5-HT7 receptor via its basal
level of activation and possibly through neuroplastic processes
[57].
Therefore, we can assume that the positive effect of adolescent
exposure to 0.250 mg/kg LP-211 on SSA, in association with
enhanced levels of amino acids and DAT in the PFC and VS, is
possibly due to the stimulation of serotonergic more effective
transducers independent of CaMKIIa. Alternatively, this positive
effect might be explained by more complex circuits, leading -
eventually - to the re-modeling of cognitive maps: in this context,
recent findings [33] point to enhanced transmission between
limbic networks including the hippocampus, that might explain
the improved SSA (essential to build spatial maps). Furthermore,
the same approach has confirmed the hypothesis that the
mesocortical DA branch is, in the NHE rat model, at a higher
functional state [14,16,17]. In addition, the subchronic treatments
using other selective agonists of the 5-HT7 receptors, during the
prepuberal period, may induce medium/long term effects on
selective spatial attention, underpinned by synaptic markers such
as DAT, NMDAR1 but not CaMKIIa.
Finally, the concentration of CaMKIIa [28], which is a
coincidence spatio-temporal detector device, was reduced in the
PFC of NHE rats under basal conditions and increased in the DS
as compared to NRB. Interestingly, the reduced CaMKIIa levels
in the PFC were associated with a reduced spatial orientation of
the NHE rats in the Olton’s maze. On the other hand, adolescent
exposure to LP-211 did not change the level of CaMKIIa in the
forebrain, but significantly improved the SSA. In fact, as
mentioned in the Introduction, CaMKIIa is a molecular device
that integrates neural signals at higher complexity levels, as
demonstrated by Yovell and Abrams [58]. They studied the
phosphorylation of the Aplysia membrane proteins by this kinase
in the presence of serotonin. The CaMKIIa protein is localised
Figure 8. Level of CaMKIIa protein measured in the PFC (panel A), DS (panel B) and VS (panel C) of NHE and NRB rats under basal
conditions. Data are presented as mean 6 standard error. For statistical analysis see the Results section (* p,0.05).
doi:10.1371/journal.pone.0083003.g008
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mainly at post-synaptic level, but it is also present at pre-synaptic
levels. The addition of calcium and serotonin within 8 sec
significantly increased the phosphorylation of the Aplysia mem-
brane proteins by the kinase, thereby demonstrating a classical
Pavlovian conditioning in a test tube [58,59].
Interestingly, recent findings from our laboratory do point to a
disintegrated interface in the PFC of NHE rats, as monitored by
immuno-chemical markers [60]. This, in turn, might explain a
functional ‘‘vulnus’’ in the default mode network that includes the
medial PFC, anterior cingolate, as well as lateral-parietal and
temporal cortices, as proposed in [61–65].
Materials and Methods
Animals
Prepuberal male rats of the Sprague–Dawley-derived NHE line
(n = 24) and of the NRB control line (n = 24), from our animal
colony, were used throughout the experiments. Rats were housed
in groups of two inside Makrolon cages
(425 mm6266 mm6150 mm, floor area 820 cm2; Techniplast,
Italy) under standard conditions. An artificial 12:12 reverse light–
dark (LD) cycle was obtained by turning on the lights from 7 pm to
7 am. All other parameters fulfilled the requirements of the Guide
for the Care and Use of Laboratory Animals, implemented by the
Italian Legislative Decree 116/1992 that covers all scientific
procedures involving the use of live animals. The European
Figure 9. Level of CaMKIIa protein measured by western blot in NHE (panel A) and NRB (panel B) rats after adolescent treatment
with 0.125 or 0.250 mg/kg LP-211. Data are presented as % of vehicle response 6 standard error.
doi:10.1371/journal.pone.0083003.g009
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Directive 2010/63 on the protection of animals used in scientific
experiments, revisioning the Directive 86/609, is currently being
enacted into Italian legislation, and will be applicable to future
research protocols. All present experiments were covered by an
authorisation from Ministero della Salute, for which ethical advice
was issued from Istituto Superiore di Sanita` (authorization to
AGS, n. prot. 422/2009 dated 08-04-09, duration 36 months).
The 3Rs principles were taken into account in order to seek for
alternatives to animal use, to reduce the number of animals used
and to refine the protocols for limitation of animal suffering.
Prepuberal treatment
At weaning on postnatal day (pnd) 28, rats were randomly
assigned to treatment and control groups (n = 6/group), which
received i.p. vehicle or LP-211 (0.0, 0.125, 0.250 or 0.500 mg/kg).
LP-211 was dissolved in phosphate buffer (vehicle) with 1% and
2% DMSO for the lower doses and the highest one, respectively.
Treatments were given daily during the dark phase between 10:00
am and 11:00 am, for 14 days from pnd 30–31 to 43–44, as
already published [40]. Thirty days after last drug or vehicle
injection, all the rats were tested in the La`t maze and, 24 hrs later,
in the eight-arm radial maze (Olton’s maze).
Drugs
A new selective 5-HT7 receptor agonist, namely N-(4-
cyanophenylmethyl)-4-(2-diphenyl)-1-piperazinehexanamide (LP-
211), was synthesized and provided by EL and ML [12]; drug
dosage was chosen according to previous experience [40] by GL
and WA. DMSO was obtained from Sigma-Aldrich (Milano,
Italy).
La`t-maze
Apparatus. The La`t-maze consisted of a 60 cm660 cm6
40 cm box made of special poly-vinyl-chloride (PVC) material
(KO¨MACELR), closed by a cover of the same material. A smaller
transparent-plastic 30 cm630 cm640 cm box was inserted in the
middle, thus providing a 60 cm long, 15 cm wide and 40 cm high
square-shaped exploratory corridor. See [66] for details. The box
was illuminated by a white, cold 4 W lamp placed 60 cm above
the floor in the centre of the cover, providing 0.1–0.2 mW/cm2. A
set of two such boxes was located in a sound attenuated
experimental room.
Procedure. At the beginning of the dark phase of an inverted
light/dark L/D cycle (between 9 am and 4 pm), the rats were
individually exposed to the La`t-maze and allowed to explore the
corridor for 10 min. In order to minimise the interference with the
arousal state, pairs of rats from the same home cage were tested at
the same time. The animals’ behaviours were monitored by a high
resolution CCD camera and stored on a DVD recorder to be
analyzed off-line. The number of corner crossings (HA), frequency
(VA) and duration (RD) of rearings on hind-limbs, or leanings
against the walls with one or both forepaws, were measured in 1-
min blocks. The reliability index was quite high (r = 0.914;
df = 198; p,0.001). At the end of the test, the fecal boluses were
counted and the floor was wiped with a wet sponge.
Eight-arm radial maze (Olton’s maze)
Apparatus. The apparatus consisted of eight arms
(8 cm660 cm) extending from an octagonal centre platform
(18.5 cm diameter). The distance from the platform centre to
the end of each arm was 69.25 cm. The apparatus was constructed
of grey PVC with a smooth surface, and side walls (14 cm high,
transparent Plexiglas). The maze was placed on the floor of a
dimly lit room, surrounded by a circular higher wall without visual
cues. Rat behaviour was monitored by a high resolution CCD
camera and stored on DVD to be analysed off-line.
Procedure. In the Olton’s maze, each rat was placed on the
centre platform into a cardboard cylinder to avoid immediate
escape into an arm. The trial began with the removal of the
cylinder and the rat was allowed to explore. The main parameters
considered in the Olton’s maze were horizontal activity (HA:
number of alley visits); frequency (VA) and duration (RD) of
rearings on the hind-limbs. The number of arms visited before the
first repetition occurred (first entry, FE), and number of arms
visited before completion of visits to all eight arms (number of visits
to criterion, NVTC), were also recorded. The latter two indices
are markers of non-reinforced SSA.
Dissection of brain areas
The animals were sacrificed by a guillotine at pnd 77. The brain
was removed and put on a surface of ice-cold saline. After removal
of the olfactory tubercles, the first coronal cut was made at 4.20
AP from Bregma, using the stereotaxic coordinates of The Rat Brain
Atlas as reference [67]. By this method, a tiny tissue included both
PFC and cingulate cortex area 1. The entire upper portion of the
striatum (i.e. DS), which included the caudate-putamen (CPu) and
globus pallidus (CG), was removed by a sagittal pinch extending
between 2.20 and 23.8 AP, up to 7 mm DV in depth. Then,
ventral striatum (i.e. VS) was removed by sagittal pinch between
2.70 to 0.48 AP, 1 mm from the midline and about 1 mm in
depth, thus including the nucleus accumbens.
Amino acids
Extraction procedure. Vehicle, LP-211 0.125 and
0.250 mg/kg groups were analysed. The 0.500 mg/kg group
was excluded because it did not show any significant effect in the
behavioural analysis. Brain samples were homogenised in 1 ml ice-
cold saline in an Eppendorf and centrifuged at 7,500 g at 4uC for
20 min. The supernatant was filtered and used for LC/MS/MS
analysis of the free amino acids L-Glu, L-Asp and L-Leu.
Liquid chromatography/tandemmass spectrometry. The
detection was performed using a Varian 310-MS triple
quadrupole mass spectrometer (Varian, Palo Alto, CA, USA).
All the analytes were detected in the positive ionisation mode
and with selected reaction monitoring (SRM) mode ( Table 1).
The settings of the ESI source were as follows: spray voltage,
5000 V; capillary temperature 300uC; sheath gas pressure
(spraying), 20 arbitrary units; auxiliary gas pressure (desolvating),
10 arbitrary units; and ion sweep gas pressure (curtain), 5
arbitrary units. The collision cell (Q2) pressure was 2.2 mTorr
of argon. The collision energies were optimised for maximum
detection of each product ion ( Table 1). Chromatographic
separation was achieved with a ProStarTM 300 HPLC system
(Varian, Palo Alto, CA, USA) on a Varian PolarisH C18column
(5 mm, 2.1 mm6100 mm) at a flow rate of 0.3 mL/min. The
mobile phase consisted of aqueous 0.1% formic acid (A) and
acetonitrile (B). Samples were eluted with a linear gradient from
10 to 90% B in 5 min. At 5:01 min, solvent B was decreased
from 90% to 10% and remained constant for 5 min. The total
run time was 10 min.
CaMKIIa, DAT, and NMDAR1
Protein extracts. Membrane and cytosolic protein fractions
were prepared as described in [68] with minor modification.
Tissues were homogenized in a glass/Teflon potter in cold 0.32 M
sucrose buffer pH 7.4 containing 1 mM HEPES, 0.1 mM EGTA
and 0.1 mM phenylmethylsulfonyl fluoride, in the presence of
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commercial cocktails of protease (Roche, Monza, Italy) and
phosphatase (Sigma-Aldrich) inhibitors. The homogenate was
centrifuged at 1,000 g for 10 min resulting in a pellet (P1) that
corresponded to the nuclear fraction. The supernatant (S1) was
then centrifuged at 13,000 g for 15 min to obtain a clarified
fraction of cytosolic proteins (S2) and a pellet (P2) corresponding to
the crude membrane fraction. The latter was homogenised in a
glass/Teflon potter in 1% Triton X-100 buffer containing 50 mM
Tris-HCl pH 7,4–300 mM NaCl, 5 mM EDTA and 0,02%
Sodium Azide. The total protein content was measured according
to the Bradford Protein Assay procedure (Bio-Rad, Milan, Italy),
using bovine serum albumin as the calibration standard.
Gel electrophoresis and immunoblotting. Sodium dode-
cyl sulfate-polyacrylamide gel electro-phoresis (SDS-PAGE) and
transfer of proteins to nitrocellulose membranes were performed
according to conventional methods with minor modifications. The
proteins were solubilised in loading buffer at 54uC for 45 min, and
then separated on 10% polyacrylamide gels and transferred onto
PVDF membranes (GE Healthcare) in transfer buffer (25 mM
Tris, 192 mM glycine, pH 8.3, 20% methanol). The membranes
were incubated with blocking buffer, 5%ECL blocking agent (GE
Healthcare) in PBST (0.1 M phosphate buffered saline, pH 7.4,
0.1% Tween-20), for 1 h at room temperature. The blots were
incubated overnight at 4uC with one of the following primary
antibodies: NMDAR1 (1:300 anti-NMDAR1; Chemicon-Milli-
pore AB9864); CaMKIIa (1:2000 Anti-CaM Kinase IIa, Clone
6G9; Upstate-Millipore #05-532); DAT (1:500 anti-Dopamine
Transporter; Millipore AB2231); internal standard: Actin (1:500
anti-Actin; Sigma A2066); or Actin (1:3000 anti–Actin, Clone C4;
Chemicon-Millipore MAB1501).
After three 10 min washes in PBST, the blots were incubated
for 1 h at room temperature with horseradish peroxidase-
conjugated secondary antibody (anti-rabbit or anti-mouse ECL
anti-rabbit IgG, HRP-linked Whole Ab; GE Healthcare NA934,
NA931). After washing, immuno-complexes were visualised by
chemiluminescence using the ECL western blotting kit (GE
Healthcare) according to the manufacturer’s instructions. All
protein bands were within linear range of the standard curves, and
were normalised to actin levels on the same membrane. Quantity
One software (BioRad Laboratories, Hercules, CA, USA) was used
for standardisation and quantisation of protein bands obtained by
western blot analysis.
Statistics
The fulfilment of the requirements for parametric analysis
(normality, variance, etc.) was assessed by specific tests (Kolmo-
gorov–Smirnov and Levene, Box test of equality of covariance
matrices) and appropriate transformations were used when
necessary. Behavioural variables in the La`t and Olton’s radial
maze were submitted to a one-way factorial analysis of variance
(ANOVA) for treatment followed by post-hoc test LSD for single
comparison.
Defecation scores were submitted to a non-parametric test by
Kruskal–Wallis. The rejection level was set at p.0.05 after
correction of the alpha-level by the Ho¨lm’s procedure [69]. All
statistical analyses on behavioural and neurochemical data were
performed by SPSS software. All data are stored on a hard disk of
a PC in our laboratory and a back-up copy in also saved in a
mobile HD unit. They will be kept at least for the next ten years
and can be made available on request.
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